All R&D articles – Page 3
-
BusinessMerger fever sweeps pharma
The life sciences sector has been gripped by a mergers and acquisition frenzy, and it looks set to continue. But what does it mean for the industry?
-
Business
Grabbing slices of the immuno-oncology pie
Another spate of immuno-oncology dealmaking adds to fervour in pharma’s ‘hottest space’
-
Opinion
Be careful what you wish for
Measuring R&D productivity is a thorny issue. Dennis Lendrem urges the pharmaceutical industry to learn from its mistakes.
-
News
Spending targets for German R&D lack ambition
Expert commission says Germany can do better than goal of investing 3% of GDP on R&D by 2015
-
Business
Big pharma opens up abandoned drugs
Seven firms will make 68 stalled compounds available for academic research
-
News
China poised to become top science spender
Budgetary pressures on EU, Japan and the US have positioned China to be the highest R&D funder by around 2019, OECD says
-
News
R&D share for basic research in China dwindles
Warning that the country is too dependent on industry research that lacks novelty
-
Business
Piramal exits drug discovery in India
Company will concentrate on generic medicines and clinical and contract research.
-
News
Future direction of Dutch science considered
Role of private industry heads a number of issues that confront how science is put to work for society
-
News
French science needs flexibility to compete on the global stage
More money needs to be diverted to smaller research groups, while government support for industry research should be simplified
-
Business
Biotech bounced back in 2013, says report
R&D investment increasing, but industry needs to use its cash more wisely
-
Business
Pharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
Business
Megamerger brings Actavis into R&D race
$25bn Forest Labs takeover will see generics giant take on patented products
-
Business
Nike eliminates water at new Taiwanese dyeing plant
ColorDry process uses supercritical CO2 to reduce waste and cut costs
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DuPont expands Chinese site
Chemical firm’s Shanghai based R&D centre will grow by 17,500 square metres and house 150 more researchers
-
Business
GSK forms Brazilian sustainable chemistry venture
Agreement with research organisation will launch centre for greener, cleaner drug production
-
Business
GSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments
